Skip to main content

Advertisement

Table 8 Mood and concentration profiles

From: Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use

Variable T1 T2 T3 Time*group Time*group*gender
POMS Tension
 PLA 13 ± 4 13 ± 5 14 ± 4 Time p = 0.09 G*T*Ge p = 0.61
 LD 13 ± 3 14 ± 5 14 ± 4 G*T p = 0.98
 HD 14 ± 4 15 ± 4 15 ± 4
POMS Depression
 PLA 16 ± 3 16 ± 4 17 ± 4 Time p = 0.12 G*T*Ge p = 0.47
 LD 16 ± 2 17 ± 5 17 ± 3 G*T p = 0.55
 HD 17 ± 2 18 ± 6 17 ± 5
POMS Anger
 PLA 13.3 ± 2.4 13.9 ± 2.8 14.0 ± 3.7 Time p = 0.50 G*T*Ge p = 0.97
 LD 13.0 ± 1.8 13.7 ± 4.2 13.5 ± 3.6 G*T p = 0.65
 HD 13.7 ± 2.4 13.4 ± 2.1 13.5 ± 2.9
POMS Vigor
 PLA 22 ± 5 22 ± 6 21 ± 6 Time p= 0.021 G*T*Ge p= 0.044
 LD 23 ± 5 19 ± 6 23 ± 6 G*T p= 0.006
 HD 21 ± 5 20 ± 6 19 ± 5
POMS Fatigue
 PLA 11 ± 3 12 ± 5 14 ± 5 Time p= 0.031 G*T*Ge p = 0.79
 LD 11 ± 4 12 ± 5 11 ± 4 G*T p = 0.41
 HD 13 ± 5 14 ± 5 15 ± 6
POMS Confusion
 PLA 12 ± 2 13 ± 3 13 ± 3 Time p = 0.64 G*T*Ge p = 0.22
 LD 13 ± 2 13 ± 2 13 ± 3 G*T p = 0.65
 HD 13 ± 3 14 ± 4 13 ± 3
POMS Total
 PLA 44 ± 13 45 ± 17 49 ± 16 Time p= 0.023 G*T*Ge p = 0.62
 LD 43 ± 10 50 ± 20 45 ± 15 G*T p = 0.50
 HD 51 ± 15 58 ± 23 58 ± 20
  1. Abbreviations: PLA Placebo, LD Theacrine Low Dose, HD Theacrine High Dose, G Group, T Time, Ge Gender
  2. Symbols: , increase from corresponding T2 value within the male TC-LD group (p < 0.05); , different from corresponding T1 value (p < 0.05). Items in bold indicate a significant effect (p < 0.05) was observed